This report describes bone safety and histomorphometric data across different dose levels and dosing frequencies of risedronate. Normal bone structure and histomorphometric data were observed, with ongoing bone remodeling and mineralization regardless of dose. These data are reassuring and do not suggest compromised bone remodeling during treatment with established risedronate regimens.
Pharmacology, Toxicology and Pharmaceutical Science
4
10%
Nursing and Health Professions
2
5%
Agricultural and Biological Sciences
2
5%
Business, Management and Accounting
1
3%
Other
1
3%
Unknown
16
41%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2021.
All research outputs
#6,082,185
of 22,931,367 outputs
Outputs from Osteoporosis International
#1,032
of 3,626 outputs
Outputs of similar age
#64,733
of 256,477 outputs
Outputs of similar age from Osteoporosis International
#14
of 83 outputs
Altmetric has tracked 22,931,367 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,626 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 256,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.
